Skip to main content

Table 1 Patient Demographics and Pre-Sampling Data

From: The impact of polymerase chain reaction (PCR) on diagnosis and management of infectious uveitis at a tertiary care facility

Age

 

51.2 (mean)

 

10–89 (range)

Gender

 Male

59 (55%)

 Female

49 (45%)

Site of PCR

 Aqueous Tap

65 (60.2%)

 Vitreous Tap

43 (39.8%)

Presenting Visual Acuity (logMAR)

 Range

0.00–3

 Median

1.2

According to anatomical site

 Anterior uveitis

28 (25.9%)

 Intermediate uveitis

2 (2%)

 Posterior uveitis

16 (14.8%)

 Panuveitis

45 (41.7%)

 Anterior + intermediate uveitis

4 (3.7%)

According to duration

 Acute uveitis

48 (44.4%)

 Chronic uveitis

55 (51%)

 Recurrent uveitis

5 (4.6%)

Pre-sampling diagnosis

 Pre-sampling diagnosis not related to PCR

19 (17.6%)

 Pre-sampling diagnosis related to PCR

28 (26%)

 Unknown

61 (56%)

Initial Treatment

 Immunosupression

22 (20%)

 Antivirals

45 (41.7%)

 Antibiotics and/or Antifungals

30 (27.8%)

 Vitrectomy

14 (13%)

 Topical agents

69 (63.9%)